Offers comprehensive support from early-phase studies to bioequivalence trials
A comprehensive third-class Grade A hospital
A specialized third-class Grade A oncology hospital
In Nantong, the DMPK (Drug Metabolism and Pharmacokinetics) division operates over 18,000 m² of advanced R&D laboratories.
Facilities include internationally compliant non-rodent animal suites and high-throughput non-GLP bioanalysis labs. Supported species: dog, monkey, mini pig, rabbit, and ferret. End-to-end support from early discovery to regulatory submission.
BioMice provides high-quality animal models and premium preclinical research services, holding full AAALAC accreditation (2016, 2019 and 2022).
Fully licensed for laboratory animal production and use (Jiangsu province), and certified for animal export.
Innostar Biotech operates 54,000 m² of modern GLP-compliant facilities, certified by NMPA, OECD, U.S. FDA, and AAALAC.
Services include early drugability assessment, non-clinical efficacy, pharmacokinetics, safety studies, clinical trial bioanalysis, radiological imaging and ophthalmic evaluation.
